AI-generated summary
The authors report two separate open-label trials of picosecond lasers for infraorbital dark circles. In one, a single session of 532 and 1,064 nm treatment did not significantly improve hyperpigmentation, while three sessions of 755 nm treatment in a small group were associated with significant improvement that was maintained through day 132. Adverse events were described as mild and temporary.
- Who or what was studied
- Adult subjects with infraorbital dark circles: 19 treated with 532 and 1,064 nm lasers and 10 treated with the 755 nm laser
- Wavelengths
- 755, 532 nm
- Limits stated in the abstract
- The trials were non-comparative, open-label, evaluator-blinded studies with small samples.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 532 nm, 755 nm, 064 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.